Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Edward Gardner

Concepts (274)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
49
2025
3210
3.520
Why?
Anti-HIV Agents
24
2025
914
2.390
Why?
Antiretroviral Therapy, Highly Active
8
2025
278
1.740
Why?
HIV Protease Inhibitors
5
2019
69
1.460
Why?
HIV-1
13
2024
911
1.410
Why?
Anti-Retroviral Agents
5
2021
250
1.390
Why?
Viral Load
12
2025
525
1.260
Why?
Medication Adherence
9
2019
535
1.040
Why?
Drug Substitution
2
2025
62
0.930
Why?
HIV Integrase Inhibitors
3
2024
80
0.890
Why?
Drug Utilization Review
1
2025
60
0.890
Why?
Continuity of Patient Care
3
2021
297
0.850
Why?
Tenofovir
10
2024
300
0.820
Why?
Adenine
10
2024
338
0.780
Why?
Patient Compliance
5
2017
587
0.730
Why?
Drug Resistance, Viral
5
2011
126
0.720
Why?
Drug Monitoring
6
2019
399
0.690
Why?
HIV
5
2025
249
0.570
Why?
Darunavir
1
2019
20
0.570
Why?
Heterocyclic Compounds, 3-Ring
1
2019
44
0.560
Why?
Organophosphates
6
2020
179
0.550
Why?
Mass Screening
7
2025
1300
0.540
Why?
Emtricitabine
8
2019
209
0.530
Why?
Hepatitis C
4
2025
250
0.510
Why?
Emergency Service, Hospital
7
2025
2357
0.480
Why?
Antiviral Agents
5
2021
774
0.480
Why?
Middle Aged
42
2025
36359
0.410
Why?
Healthcare Disparities
1
2021
728
0.410
Why?
Acquired Immunodeficiency Syndrome
1
2015
237
0.410
Why?
Health Services Administration
1
2013
9
0.400
Why?
Male
54
2025
73014
0.390
Why?
Adult
48
2025
40821
0.390
Why?
Alanine
3
2024
171
0.390
Why?
Hepacivirus
4
2025
236
0.390
Why?
Public Health Administration
1
2013
69
0.370
Why?
Humans
70
2025
145625
0.370
Why?
Sustained Virologic Response
2
2025
47
0.370
Why?
Female
53
2025
79080
0.370
Why?
Pneumococcal Infections
2
2024
104
0.350
Why?
RNA, Viral
5
2025
691
0.350
Why?
Pyrrolidinones
1
2011
29
0.340
Why?
CD4 Lymphocyte Count
7
2019
280
0.340
Why?
Drug Therapy, Combination
7
2021
1034
0.340
Why?
Streptococcus pneumoniae
2
2024
187
0.330
Why?
Reverse Transcriptase Inhibitors
2
2008
88
0.320
Why?
Antibodies, Neutralizing
3
2025
346
0.320
Why?
Fees and Charges
1
2010
12
0.310
Why?
Current Procedural Terminology
1
2010
18
0.310
Why?
Patient Education as Topic
3
2016
769
0.310
Why?
Pyridones
2
2024
210
0.300
Why?
Online Systems
1
2009
20
0.300
Why?
Outpatient Clinics, Hospital
1
2010
80
0.300
Why?
Dried Blood Spot Testing
4
2019
129
0.300
Why?
Fibromyalgia
1
2009
52
0.290
Why?
Delivery of Health Care
3
2014
942
0.280
Why?
Drug Overdose
3
2019
376
0.280
Why?
Rheumatology
1
2010
136
0.270
Why?
Clostridium butyricum
1
2008
2
0.270
Why?
Organophosphonates
3
2015
95
0.270
Why?
Deoxycytidine
3
2015
219
0.260
Why?
Cost-Benefit Analysis
2
2024
632
0.260
Why?
Clostridium Infections
1
2008
73
0.250
Why?
Lupus Erythematosus, Systemic
1
2009
240
0.250
Why?
Naloxone
3
2018
138
0.240
Why?
Retrospective Studies
12
2025
17291
0.240
Why?
Prospective Studies
13
2025
8087
0.230
Why?
Treatment Outcome
11
2025
11744
0.230
Why?
Narcotic Antagonists
3
2018
209
0.230
Why?
Urban Health Services
1
2025
68
0.220
Why?
Kartagener Syndrome
1
2005
31
0.220
Why?
Health Care Costs
2
2011
418
0.220
Why?
Molecular Epidemiology
1
2005
74
0.220
Why?
Immunization, Passive
1
2025
90
0.220
Why?
Macrolides
1
2005
68
0.220
Why?
Drug Resistance, Multiple, Bacterial
1
2005
77
0.220
Why?
Analgesics, Opioid
4
2019
1158
0.220
Why?
Lymphocyte Activation
3
2021
1136
0.220
Why?
Blood Chemical Analysis
3
2014
109
0.220
Why?
Antibodies, Monoclonal, Humanized
2
2021
992
0.220
Why?
Anus Neoplasms
1
2025
33
0.210
Why?
Lymphopenia
1
2025
62
0.210
Why?
Mycobacterium avium-intracellulare Infection
1
2005
63
0.210
Why?
Nasopharynx
1
2024
72
0.210
Why?
Time Factors
5
2025
7079
0.210
Why?
Adenosine Monophosphate
2
2021
87
0.200
Why?
Patient Acceptance of Health Care
1
2011
880
0.200
Why?
Respiratory Tract Infections
2
2024
399
0.200
Why?
Raltegravir Potassium
2
2015
18
0.200
Why?
Desiccation
2
2014
26
0.200
Why?
Abnormalities, Multiple
1
2005
193
0.200
Why?
Pre-Exposure Prophylaxis
3
2017
272
0.190
Why?
Cohort Studies
6
2025
6045
0.190
Why?
Specimen Handling
2
2014
178
0.180
Why?
Quality of Life
3
2025
3187
0.170
Why?
Sepsis
1
2008
668
0.170
Why?
Vaccines, Conjugate
1
2021
60
0.170
Why?
Viremia
2
2019
158
0.160
Why?
Arthritis, Rheumatoid
1
2009
1184
0.160
Why?
Weight Gain
1
2024
561
0.160
Why?
Research Subjects
1
2020
42
0.160
Why?
AIDS-Related Opportunistic Infections
1
2021
130
0.150
Why?
Pneumococcal Vaccines
1
2021
130
0.150
Why?
Substance-Related Disorders
2
2018
1098
0.150
Why?
Adaptive Immunity
1
2021
172
0.150
Why?
Gender Identity
1
2020
132
0.150
Why?
Internship and Residency
1
2010
1269
0.140
Why?
Oxazines
1
2019
36
0.140
Why?
Time-to-Treatment
1
2021
257
0.140
Why?
Sexual and Gender Minorities
2
2020
268
0.140
Why?
Leukocytes, Mononuclear
3
2016
585
0.140
Why?
Randomized Controlled Trials as Topic
4
2025
1754
0.140
Why?
Colorado
5
2018
4588
0.140
Why?
Rectum
2
2016
180
0.130
Why?
Directly Observed Therapy
1
2017
16
0.130
Why?
Atazanavir Sulfate
2
2015
41
0.130
Why?
Drug Administration Schedule
4
2018
782
0.130
Why?
Microbiota
1
2024
724
0.130
Why?
Terminology as Topic
1
2019
253
0.120
Why?
B-Lymphocytes
2
2021
884
0.120
Why?
Genitalia
1
2016
32
0.120
Why?
Homosexuality, Male
2
2016
231
0.120
Why?
Piperazines
1
2019
367
0.120
Why?
Secondary Prevention
1
2017
247
0.110
Why?
Chronic Pain
2
2018
302
0.110
Why?
Genitalia, Female
1
2015
43
0.110
Why?
Enzyme-Linked Immunosorbent Assay
2
2014
845
0.110
Why?
Coinfection
1
2016
143
0.110
Why?
Mental Health Services
1
2019
449
0.100
Why?
Disease Transmission, Infectious
1
2014
69
0.100
Why?
Young Adult
10
2024
14240
0.100
Why?
Lost to Follow-Up
1
2013
19
0.100
Why?
Biomarkers
6
2021
4329
0.100
Why?
Immunologic Factors
1
2015
244
0.090
Why?
Equivalence Trials as Topic
2
2023
34
0.090
Why?
Aged
9
2025
26251
0.090
Why?
Risk Factors
5
2025
10840
0.090
Why?
Vaccination
1
2021
1444
0.090
Why?
Genotype
2
2025
1866
0.090
Why?
Zidovudine
1
2012
75
0.090
Why?
Lamivudine
1
2012
63
0.090
Why?
United States
4
2024
16041
0.080
Why?
Intention to Treat Analysis
2
2021
78
0.080
Why?
Population Surveillance
1
2014
477
0.080
Why?
Lymphoma, AIDS-Related
1
2010
13
0.080
Why?
Mental Disorders
1
2019
1133
0.080
Why?
Treatment Failure
2
2021
358
0.080
Why?
Acidosis, Lactic
1
2010
46
0.080
Why?
T-Lymphocytes
1
2018
2007
0.080
Why?
Chromatography, Liquid
3
2019
452
0.080
Why?
Socioeconomic Factors
1
2014
1323
0.080
Why?
Case-Control Studies
3
2021
3633
0.070
Why?
alpha 1-Antitrypsin
1
2010
104
0.070
Why?
Cytochrome P-450 CYP3A
1
2009
93
0.070
Why?
Tandem Mass Spectrometry
3
2019
574
0.070
Why?
Adolescent
8
2021
22451
0.070
Why?
Public Health
1
2013
573
0.070
Why?
Hospitalization
3
2025
2468
0.070
Why?
Comprehension
1
2009
175
0.070
Why?
Health Knowledge, Attitudes, Practice
1
2016
1403
0.070
Why?
Oligopeptides
1
2009
264
0.070
Why?
Cost Savings
1
2008
85
0.060
Why?
Educational Status
1
2009
466
0.060
Why?
Disease Progression
2
2023
2857
0.060
Why?
Drug Costs
1
2008
115
0.060
Why?
Double-Blind Method
2
2021
2064
0.060
Why?
Substance Abuse, Intravenous
1
2008
131
0.060
Why?
Catheterization, Central Venous
1
2008
120
0.060
Why?
Osteomyelitis
1
2008
146
0.060
Why?
Anti-Bacterial Agents
2
2008
1935
0.060
Why?
Axonemal Dyneins
1
2005
8
0.060
Why?
Dyneins
1
2005
34
0.060
Why?
HSP40 Heat-Shock Proteins
1
2005
26
0.060
Why?
Pyridines
1
2009
606
0.050
Why?
Analysis of Variance
1
2008
1293
0.050
Why?
Nonlinear Dynamics
1
2005
95
0.050
Why?
Inflammation
1
2016
2915
0.050
Why?
Mycobacterium avium Complex
1
2005
87
0.050
Why?
Genetic Linkage
1
2005
269
0.050
Why?
Lymphocyte Count
1
2025
166
0.050
Why?
Half-Life
2
2016
157
0.050
Why?
Heat-Shock Proteins
1
2005
140
0.050
Why?
Oropharynx
1
2024
46
0.050
Why?
Nasal Mucosa
1
2005
112
0.050
Why?
Gene Expression
1
2009
1461
0.050
Why?
Aminobutyrates
1
2024
31
0.050
Why?
Bronchiectasis
1
2005
115
0.050
Why?
Liver Neoplasms
1
2010
774
0.050
Why?
Electronic Health Records
2
2025
1208
0.050
Why?
Pilot Projects
1
2009
1878
0.050
Why?
Staphylococcal Infections
1
2008
396
0.050
Why?
Spleen
1
2005
503
0.050
Why?
Sensitivity and Specificity
1
2008
1992
0.050
Why?
Curriculum
1
2010
1074
0.050
Why?
Multivariate Analysis
1
2006
1531
0.050
Why?
Triazoles
1
2024
190
0.050
Why?
RNA, Ribosomal, 16S
1
2024
507
0.050
Why?
Logistic Models
1
2008
2112
0.050
Why?
Risk Assessment
2
2025
3678
0.050
Why?
Recurrence
1
2005
1125
0.040
Why?
Primary Health Care
3
2018
1768
0.040
Why?
Medical Futility
1
2021
32
0.040
Why?
Pragmatic Clinical Trials as Topic
1
2022
135
0.040
Why?
Inducible T-Cell Co-Stimulator Protein
1
2021
12
0.040
Why?
Ultrasonography
1
2005
788
0.040
Why?
Antibodies, Viral
1
2025
683
0.040
Why?
Immunogenicity, Vaccine
1
2021
40
0.040
Why?
Antigens, Viral
1
2021
186
0.040
Why?
Fatigue
1
2023
362
0.040
Why?
Severity of Illness Index
2
2025
2910
0.040
Why?
Antibodies, Bacterial
1
2021
147
0.040
Why?
Multicenter Studies as Topic
1
2022
413
0.040
Why?
Mutation
1
2011
4082
0.040
Why?
Transsexualism
1
2020
21
0.040
Why?
Plasma
2
2012
222
0.040
Why?
Intercellular Adhesion Molecule-1
1
2019
132
0.040
Why?
Fibrin Fibrinogen Degradation Products
1
2019
92
0.040
Why?
Odds Ratio
1
2021
1070
0.030
Why?
Follow-Up Studies
1
2008
5397
0.030
Why?
Qualitative Research
2
2016
1720
0.030
Why?
International Classification of Diseases
1
2019
142
0.030
Why?
Antibodies, Monoclonal
1
2025
1511
0.030
Why?
Attitude of Health Personnel
2
2016
1212
0.030
Why?
Health Services Accessibility
1
2006
1101
0.030
Why?
Immunophenotyping
1
2018
324
0.030
Why?
Clinical Studies as Topic
1
2016
12
0.030
Why?
Liver
1
2005
1859
0.030
Why?
Longitudinal Studies
2
2016
3005
0.030
Why?
Cell Communication
1
2018
327
0.030
Why?
Glucocorticoids
1
2020
536
0.030
Why?
Ribavirin
1
2016
81
0.030
Why?
Spermatozoa
1
2016
103
0.030
Why?
Cross-Over Studies
1
2017
612
0.030
Why?
Interleukin-6
1
2019
782
0.030
Why?
Health Status
1
2020
822
0.030
Why?
Blood
1
2015
107
0.030
Why?
Tomography, X-Ray Computed
1
2005
2766
0.030
Why?
Comorbidity
1
2019
1652
0.030
Why?
Hepatitis C, Chronic
1
2016
149
0.030
Why?
Risk
1
2016
917
0.030
Why?
Cross-Sectional Studies
2
2019
5875
0.030
Why?
Predictive Value of Tests
1
2019
2097
0.020
Why?
Models, Statistical
1
2018
667
0.020
Why?
Drug Prescriptions
1
2015
290
0.020
Why?
Physicians, Primary Care
1
2015
209
0.020
Why?
Mental Health
1
2019
771
0.020
Why?
T-Lymphocyte Subsets
1
2015
415
0.020
Why?
Focus Groups
1
2015
587
0.020
Why?
Dideoxynucleotides
1
2012
17
0.020
Why?
Cytidine Triphosphate
1
2012
19
0.020
Why?
Thymine Nucleotides
1
2012
19
0.020
Why?
Self Report
1
2016
869
0.020
Why?
Food-Drug Interactions
1
2010
11
0.020
Why?
Reproducibility of Results
1
2019
3396
0.020
Why?
Chemoprevention
1
2010
91
0.020
Why?
Epithelial Cells
1
2016
1118
0.020
Why?
Vincristine
1
2010
148
0.020
Why?
Cyclophosphamide
1
2010
275
0.020
Why?
Fatal Outcome
1
2010
302
0.020
Why?
Prednisone
1
2010
229
0.020
Why?
Drug Interactions
1
2010
403
0.020
Why?
Ritonavir
1
2009
75
0.020
Why?
Prognosis
1
2018
4331
0.020
Why?
Doxorubicin
1
2010
414
0.020
Why?
Haplotypes
1
2009
505
0.020
Why?
Clinical Competence
1
2015
1261
0.020
Why?
Polymorphism, Genetic
1
2009
611
0.020
Why?
Erythrocytes
1
2012
749
0.020
Why?
Sequence Analysis, DNA
1
2009
771
0.020
Why?
Animals
1
2009
38030
0.010
Why?
Sex Factors
1
2012
2101
0.010
Why?
Aged, 80 and over
1
2018
8351
0.010
Why?
Molecular Sequence Data
1
2009
2835
0.010
Why?
Surveys and Questionnaires
1
2017
6050
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1996
0.010
Why?
Gardner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)